You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
20 April 2026 - Clinical-stage biopharmaceutical company Accent Therapeutics on Friday presented preclinical data supporting its potentially best-in-class KIF18A inhibitor, ATX-295, at the American Association for Cancer Research (AACR) Annual Meetin...
20 April 2026 - Life science technology company 10x Genomics Inc (Nasdaq:TXG) on Saturday introduced Atera, an in situ spatial biology platform designed to deliver whole-transcriptome spatial analysis with single-cell sensitivity at unprecedented sca...
17 April 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Friday that the European Commission has approved ENFLONSIA (clesrovimab) for the prevention of respiratory syncytial virus (...
17 April 2026 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Friday that it has obtained Marketing Authorization in Denmark for Palbociclib Newbury tablets, marking the first approval within a Scandinavian regis...
17 April 2026 - Canadian clinical-stage biopharmaceutical company Bold Therapeutics Inc on Thursday released new data highlighting the ability of its lead asset, BOLD-100, to demonstrate protective effects against chemotherapy-induced peripheral neur...